drugset / Trial / NCT02993328
A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) for Treatment of Plaque Psoriasis in Adults
Phase 2
Withdrawn
Santalis Pharmaceuticals, Inc.
ClinDatrix, Inc. · collabFremantle Dermatology · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This trial will be a double-blind, single-center, randomized, placebo controlled study to evaluate the safety, tolerability, and efficacy of SAN021 study drug when administered for up to 42 days to adults between the ages of 18 to 65 years who have a clinical diagnosis of mild-to-moderate plaque psoriasis.
Timeline
- Start
- 2018-06-10
- Primary completion
- 2019-01-01
- Completion
- 2019-01-01
Outcome
Outcome not reported
Stopped: “Study location changed”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SAN021 | Traditional medicine (herbal / TCM) | 5 unknown | Topical |